Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

3.36
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.01
Today|||52-Week Range
3.39
+220.00%
Year-to-Date
Catalyst Initiates Phase II Study for Pipeline Drug Firdapse
Nov 22 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q3
Nov 09 / Zacks.com - Paid Partner Content